Improving the Quality of Life of Latin American Patients
M8 provides healthcare professionals and patients with access to proven treatments they need to thrive. We serve as a comprehensive source of expertise in each of the following therapeutic areas.
Central Nervous System
- Mokbio®(Lactobacillus plantarum 128)
- Haldol®(Haloperidol )
- Nabota®(Botulinum Toxin type A)
- Reminyl®(Galantamine Bromhide)
Reliable, Convenient Service and Support for Professionals and Patients
Partner with Us
From go-to-market strategy and registration to access and long-term market presence, M8 is a purpose-built biopharmaceutical platform that supports the entire development-commercialization continuum.
Our Commitment to Latin America
Six core values guide us on our mission to provide support to the patients and healthcare professionals of Latin America.
Fexuprazan is an inhibitor of competitive acid secretion with potassium (P-CAB), which reversibly blocks the proton pump that secretes gastric acids from the stomach walls. It is a novel investigational drug for gastroesophageal reflux disease.